| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 75,082 | 50,352 | | Cost of Revenue | 21,451 | 14,880 | | | Gross Profit | 53,631 | 35,472 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 4,116 | 1,645 | | Non Recurring |
-
|
-
| | Others | 11,865 | 9,375 | | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 37,650 | 24,452 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 324 | 93 | | Earnings Before Interest And Taxes | 37,974 | 24,545 | | Interest Expense | 9,216 | 5,522 | | Income Before Tax | 28,758 | 19,023 | | Income Tax Expense |
-
| (485) | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 28,758 | 19,508 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 28,758 | 19,508 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $28,758 | $19,508 |
|
0.51% Nasdaq 
Income Statement
